Boston Scientific And Angiotech Win Stent Suit

Law360, New York (May 4, 2006, 12:00 AM EDT) -- Medical device makers Boston Scientific Corp. and Angiotech Pharmaceuticals Inc. have emerged victorious in a patent dispute after a Dutch court ruled Sahajanand Medical Technologies Pvt. Ltd.’s drug-eluting stent violated two claims of an Angiotech patent.

The Dutch court confirmed that the Canadian drug company’s patent was valid and Sahajanand’s Infinnium paclitaxel-eluting stent infringed on it. India-based Sahajanand has been ordered to pay for damages as a result of the infringement.

The court also permitted an injunction against Sahajanand, barring the company from selling or delivering...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.